Skip to main content

Upcoming holiday closures 

Quest Patient Service Centers will be closed on Friday, July 3 and Saturday, July 4, 2026, in observance of Independence Day, and to give our frontline team the time to recharge. Don't let the holiday interrupt your care. Plan your visit today.

Hide
Quest Diagnostics

Unveiling Cellular Mechanisms Underlying MYZAP Related Dilated Cardiomyopathy Using Patient Specific hiPSC Cardiomyocytes

Unveiling Cellular Mechanisms Underlying MYZAP Related Dilated Cardiomyopathy Using Patient Specific hiPSC Cardiomyocytes

Authors: Zakzook F, Cherian RM, Prajapati C, Pekkanen-Mattila M, Ahola A, Koskenvuo J, Heliö K, Heliö T, Aalto-Setälä K

Citation: Sci Rep. 2026 Apr 21. doi: 10.1038/s41598-026-48921-5. Online ahead of print.

Specialties: Genetics, Cardiology, Cardiovascular disease

Disclaimer: One or more of the authors of this publication were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics

Related content

Publication
GRINL1A Complex Transcription Unit Containing GCOM1, MYZAP, and POLR2M Genes Associates with Fully Penetrant Recessive Dilated Cardiomyopathy
Publication
Diagnostic Yield of Genetic Testing in a Multinational Heterogeneous Cohort of 2088 DCM Patients
Publication
The junctophilin-2 mutation p.(Thr161Lys) is associated with hypertrophic cardiomyopathy using patient-specific iPS cardiomyocytes and demonstrates prolonged action potential and increased arrhythmogenicity
Publication
Recessive TMOD1 mutation causes childhood cardiomyopathy
Audio Podcast
The power of laboratory analytics
Conference Presentation
Genetic Findings for Cardiomyopathy and Arrhythmia: A Retroactive Analysis of Over 1,800 Patients
Conference Presentation
Genetic Findings From Multi-gene Panel for Inherited Myopathies
Conference Presentation
Genetic Findings in a Cohort of Over 1800 Patients Tested With a Combined Cardiomyopathy and Arrhythmia Panel

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.